vs
ROCKY BRANDS, INC.（RCKY）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是ROCKY BRANDS, INC.的1.4倍（$197.9M vs $139.7M），REPLIGEN CORP净利率更高（6.7% vs 4.7%，领先2.1%），REPLIGEN CORP同比增速更快（13.6% vs 9.1%），REPLIGEN CORP自由现金流更多（$17.6M vs $16.7M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 11.2%）
洛基品牌公司（原洛基鞋靴公司）1932年创立于俄亥俄州纳尔逊维尔，总部至今仍设于该地。公司主营户外、工装、西部风格及军用鞋靴的设计研发、生产与销售，同时也推出各类户外与工装服饰及周边配件。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
RCKY vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.4倍
$139.7M
营收增速更快
RGEN
高出4.5%
9.1%
净利率更高
RGEN
高出2.1%
4.7%
自由现金流更多
RGEN
多$833.0K
$16.7M
两年增速更快
RGEN
近两年复合增速
11.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $139.7M | $197.9M |
| 净利润 | $6.5M | $13.3M |
| 毛利率 | 41.3% | 52.5% |
| 营业利润率 | 6.9% | 9.0% |
| 净利率 | 4.7% | 6.7% |
| 营收同比 | 9.1% | 13.6% |
| 净利润同比 | 35.7% | 143.9% |
| 每股收益（稀释后） | $0.86 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RCKYRGEN
| Q4 25 | $139.7M | $197.9M | ||
| Q3 25 | $122.5M | $188.8M | ||
| Q2 25 | $105.6M | $182.4M | ||
| Q1 25 | $114.1M | $169.2M | ||
| Q4 24 | $128.1M | $174.1M | ||
| Q3 24 | $114.6M | $154.9M | ||
| Q2 24 | $98.3M | $154.1M | ||
| Q1 24 | $112.9M | $151.3M |
净利润RCKYRGEN
| Q4 25 | $6.5M | $13.3M | ||
| Q3 25 | $7.2M | $14.9M | ||
| Q2 25 | $3.6M | $14.9M | ||
| Q1 25 | $4.9M | $5.8M | ||
| Q4 24 | $4.8M | $-30.3M | ||
| Q3 24 | $5.3M | $-654.0K | ||
| Q2 24 | $-1.2M | $3.3M | ||
| Q1 24 | $2.5M | $2.1M |
毛利率RCKYRGEN
| Q4 25 | 41.3% | 52.5% | ||
| Q3 25 | 40.2% | 53.2% | ||
| Q2 25 | 41.0% | 50.0% | ||
| Q1 25 | 41.2% | 53.6% | ||
| Q4 24 | 41.5% | 26.1% | ||
| Q3 24 | 38.1% | 50.0% | ||
| Q2 24 | 38.7% | 49.8% | ||
| Q1 24 | 39.1% | 49.5% |
营业利润率RCKYRGEN
| Q4 25 | 6.9% | 9.0% | ||
| Q3 25 | 9.6% | 8.9% | ||
| Q2 25 | 6.8% | 7.6% | ||
| Q1 25 | 7.6% | 3.9% | ||
| Q4 24 | 6.6% | -17.7% | ||
| Q3 24 | 8.8% | -5.1% | ||
| Q2 24 | 4.6% | 1.0% | ||
| Q1 24 | 7.1% | 1.3% |
净利率RCKYRGEN
| Q4 25 | 4.7% | 6.7% | ||
| Q3 25 | 5.9% | 7.9% | ||
| Q2 25 | 3.4% | 8.2% | ||
| Q1 25 | 4.3% | 3.4% | ||
| Q4 24 | 3.7% | -17.4% | ||
| Q3 24 | 4.6% | -0.4% | ||
| Q2 24 | -1.3% | 2.2% | ||
| Q1 24 | 2.3% | 1.4% |
每股收益（稀释后）RCKYRGEN
| Q4 25 | $0.86 | $0.24 | ||
| Q3 25 | $0.96 | $0.26 | ||
| Q2 25 | $0.48 | $0.26 | ||
| Q1 25 | $0.66 | $0.10 | ||
| Q4 24 | $0.65 | $-0.55 | ||
| Q3 24 | $0.70 | $-0.01 | ||
| Q2 24 | $-0.17 | $0.06 | ||
| Q1 24 | $0.34 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.9M | $767.6M |
| 总债务越低越好 | $122.6M | $542.2M |
| 股东权益账面价值 | $252.1M | $2.1B |
| 总资产 | $477.5M | $2.9B |
| 负债/权益比越低杠杆越低 | 0.49× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资RCKYRGEN
| Q4 25 | $2.9M | $767.6M | ||
| Q3 25 | $3.3M | $748.7M | ||
| Q2 25 | $2.8M | $708.9M | ||
| Q1 25 | $2.6M | $697.2M | ||
| Q4 24 | $3.7M | $757.4M | ||
| Q3 24 | $3.7M | $784.0M | ||
| Q2 24 | $4.1M | $809.1M | ||
| Q1 24 | $3.1M | $780.6M |
总债务RCKYRGEN
| Q4 25 | $122.6M | $542.2M | ||
| Q3 25 | $139.0M | $537.9M | ||
| Q2 25 | $132.5M | — | ||
| Q1 25 | $128.6M | — | ||
| Q4 24 | $128.7M | $525.6M | ||
| Q3 24 | $150.3M | — | ||
| Q2 24 | $152.4M | — | ||
| Q1 24 | $156.0M | — |
股东权益RCKYRGEN
| Q4 25 | $252.1M | $2.1B | ||
| Q3 25 | $246.1M | $2.1B | ||
| Q2 25 | $239.1M | $2.1B | ||
| Q1 25 | $236.2M | $2.0B | ||
| Q4 24 | $232.2M | $2.0B | ||
| Q3 24 | $228.3M | $2.0B | ||
| Q2 24 | $223.8M | $2.0B | ||
| Q1 24 | $225.3M | $2.0B |
总资产RCKYRGEN
| Q4 25 | $477.5M | $2.9B | ||
| Q3 25 | $494.0M | $2.9B | ||
| Q2 25 | $471.0M | $2.9B | ||
| Q1 25 | $468.2M | $2.9B | ||
| Q4 24 | $457.3M | $2.8B | ||
| Q3 24 | $475.0M | $2.8B | ||
| Q2 24 | $467.9M | $2.9B | ||
| Q1 24 | $466.5M | $2.8B |
负债/权益比RCKYRGEN
| Q4 25 | 0.49× | 0.26× | ||
| Q3 25 | 0.57× | 0.26× | ||
| Q2 25 | 0.55× | — | ||
| Q1 25 | 0.54× | — | ||
| Q4 24 | 0.55× | 0.27× | ||
| Q3 24 | 0.66× | — | ||
| Q2 24 | 0.68× | — | ||
| Q1 24 | 0.69× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.6M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $16.7M | $17.6M |
| 自由现金流率自由现金流/营收 | 12.0% | 8.9% |
| 资本支出强度资本支出/营收 | 0.6% | 4.1% |
| 现金转化率经营现金流/净利润 | 2.70× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $9.7M | $93.9M |
8季度趋势，按日历期对齐
经营现金流RCKYRGEN
| Q4 25 | $17.6M | $25.7M | ||
| Q3 25 | $-3.3M | $48.1M | ||
| Q2 25 | $812.0K | $28.6M | ||
| Q1 25 | $1.2M | $15.0M | ||
| Q4 24 | $24.4M | $39.2M | ||
| Q3 24 | $4.5M | $49.3M | ||
| Q2 24 | $6.5M | $42.2M | ||
| Q1 24 | $17.4M | $44.7M |
自由现金流RCKYRGEN
| Q4 25 | $16.7M | $17.6M | ||
| Q3 25 | $-5.2M | $43.4M | ||
| Q2 25 | $-2.4M | $21.5M | ||
| Q1 25 | $529.0K | $11.4M | ||
| Q4 24 | $22.9M | $33.6M | ||
| Q3 24 | $3.5M | $42.3M | ||
| Q2 24 | $4.6M | $37.4M | ||
| Q1 24 | $17.1M | $36.4M |
自由现金流率RCKYRGEN
| Q4 25 | 12.0% | 8.9% | ||
| Q3 25 | -4.2% | 23.0% | ||
| Q2 25 | -2.2% | 11.8% | ||
| Q1 25 | 0.5% | 6.8% | ||
| Q4 24 | 17.9% | 19.3% | ||
| Q3 24 | 3.0% | 27.3% | ||
| Q2 24 | 4.7% | 24.3% | ||
| Q1 24 | 15.2% | 24.0% |
资本支出强度RCKYRGEN
| Q4 25 | 0.6% | 4.1% | ||
| Q3 25 | 1.5% | 2.5% | ||
| Q2 25 | 3.0% | 3.9% | ||
| Q1 25 | 0.6% | 2.1% | ||
| Q4 24 | 1.2% | 3.2% | ||
| Q3 24 | 0.9% | 4.5% | ||
| Q2 24 | 1.9% | 3.1% | ||
| Q1 24 | 0.2% | 5.5% |
现金转化率RCKYRGEN
| Q4 25 | 2.70× | 1.93× | ||
| Q3 25 | -0.46× | 3.23× | ||
| Q2 25 | 0.23× | 1.92× | ||
| Q1 25 | 0.25× | 2.57× | ||
| Q4 24 | 5.08× | — | ||
| Q3 24 | 0.85× | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | 6.82× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RCKY
| Wholesale | $79.6M | 57% |
| Retail1 | $57.0M | 41% |
| Contract Manufacturing | $3.2M | 2% |
RGEN
暂无分部数据
